Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6143744 | American Journal of Obstetrics and Gynecology | 2016 | 27 Pages |
Abstract
The results support the hypothesis that prophylactic treatment with tranexamic acid reduces the overall total blood loss, the incidence of substantial blood loss, and the need for reoperations owing to postoperative hemorrhage in relation to benign hysterectomy. No incidences of serious adverse events occurred. Thus, tranexamic acid should be considered as a prophylactic treatment prior to elective benign hysterectomy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Märta Fink MD, Thomas PhD, Pernille DMSc, Lars MD, Charlotte PhD, Bent DMSc, Annette PhD,